What’s SHOOT THE MESSENGER?
Well, AICN COMICS: SHOOT THE MESSENGER is your weekly one stop shop for comic book -EWS. What’s comic book –EWS? Well, it’s our hodge podge of everything not reviews here at AICN Comics. Sure you can find out the @$$Holes’ critical opinions of your favorite books every Wednesday at AICN Comics. But here, you’ll find special reports such as previews, interviews, special features, and occasionally news gathered here from our online brethren at Newsarama, CBR, Wizard, etc. Sure those guys are the best at reporting news as it breaks. Click on the links for the original stories. This column cuts the crap to run down all the vital information for those of you who don’t follow it as it comes in, and serves it all up with that special ingredient of @$$y goodness.
Welcome to another edition of Shoot the Messenger, all. Before we get started, we’ve got some sad news to report. Sheldon Dorf, founder of the San Diego Comic-Con, passed away last week at the age of 76. Last year was the first time I attended the colossal event. It was a truly a memorable experience and a testament to Mr. Dorf’s undeniable mark on the comic book industry. You can read more about his passing here. R.I.P. Sheldon Dorf…

Bug Talks TUMOR with Joshua Hale Fialkov!
Hey folks, Ambush Bug here with an extra special Q&@ this week with the writer of the hit Amazon Kindle comic book series TUMOR, Joshua Hale Fialkov. As the series comes to a close, Joshua was able to answer a few questions I lobbed his way about TUMOR, the future of comics, and the upcoming release of the hardcover collection of TUMOR from Archaia. Here’s what Joshua had to say.
AMBUSH BUG (BUG): So for those who haven't been paying attention to this awesome miniseries, can you describe the premise of TUMOR?
JOSHUA HALE FIALKOV (JHF): TUMOR is a Los Angeles noir about a p.i. who gets handed a huge moneymaking case to find and protect a missing girl on the same day that he's diagnosed with a terminal brain tumor. He decides that he's going to go out with a bang and do something right for the first time in his life. Of course, as he's protecting this girl, he's having the symptoms of a brain tumor, so, he loses time, has seizures, hallucinates, and has violent mood swings. BUG: The book has been available through Amazon Kindle. Is this the first time a book has been released that way? How did this deal come about?
JHF: We're certainly the first original graphic novel on the device. There's been comics available for some time, but they're all reprints of previously published material. For the entirety of its release TUMOR #1 has been the #1 comic on the Amazon Kindle, so that's been pretty exciting. The idea really just came out of a conversation between (Archaia bigwig) Stephen Christy and I about how much we love our kindles, and how it really captures that feel of the pulps (the screen look and feel) and comics (the serialized distribution) perfectly.BUG: You had an extremely tough time releasing the final issues of ELK'S RUN, but TUMOR seems to have run pretty smoothly and to have been released pretty consistently. What lessons did you learn in between the release of these two books?
With TUMOR, we planned on the series being a book from day one. It was always intended to be released to the world as a beautiful and substantial hardcover. With the Kindle release we got the benefit of releasing individual issues, which is a marketing and 'brand awareness' thing (look how douchey I sound!), without the financial risk. I also think that it makes people excited to finally get the book in print, both new readers and those who've followed the digital version. For me, digital first with a well designed, extras loaded collection is the way of the future.
BUG: At San Diego Comic-Con this year, there seemed to be a trend of a push to more digital comics released through iPhones and other computer avenues. How do you feel about this shift towards a more digital age of comics? Are printed comics going the way of the dinosaurs?
JHF: I think that Marvel and DC will be publishing monthly comics for a long while to come. But, you're going to start seeing less and less indie stuff delivered that way. The fact is that there's just not a lot of room in the market, or, frankly, a lot of interest for non-mainstream work. There's amazing retailers who've made it into their bread and butter, but, for the most part, most comic shops in this country subsist on the regular income of well-scheduled mainstream event comics, and random independent books from, to them, B and C level creators just don't cut it.BUG: The themes of TUMOR are definitely noir based. I detected a bit of a MEMENTO vibe in this one. What influenced you for TUMOR?
JHF: I probably owe the biggest debt to a film noir directed by Rudolph Maté from 1950 called D.O.A. (Which for the record, is not to be confused with the 80's remake or the creepy movie starring Jamie Pressley.) D.O.A. Is about a man who's poisoned and has twenty four hours to find his murderer. Yes, that's where CRANK got it from. The other big influence was a tv miniseries by Dennis Botter for the BBC called THE SINGING DETECTIVE which follows a crime novelist with a debilitating skin condition who imagines the next novel in his series of books while hallucinating about his life leading up to the point we first meet him. It's probably the best six or so hours of television ever created, and like I said, it's a masterpiece worth stealing from.BUG: You really feel for the central character of TUMOR. He is literally falling apart throughout this entire story and it's devastating to see his mind and body begin to fail due to the tumor. With such a deep emotional resonance to this story, one would assume that this is a highly personal story for yourself. Is this true or are you just that damn fine a writer?
A lot of my writing comes from my own worst nightmares, and losing my ability for cognitive thought is pretty damn far up the list. I think it's a recognizable fear for the reader as well because no matter what a person believes, at their core they know that their brain is who they are, and without it they're nothing.